18 September 2026
Aspen's turnaround hinges on filling its underused sterile manufacturing plants, as GLP-1 sales drive a share recovery.
16 February 2026
Moderna criticises the FDA as unpredictable, impacting its mRNA flu shot and the future of drug innovation in America.
10 November 2025
Biovac R&D Lab opens in Cape Town, enhancing vaccine manufacturing capabilities for Africa with support from the Gates Foundation.
7 November 2025
Aspen Pharmacare resolves its mRNA dispute with a R500m settlement, stabilising its earnings and share price significantly.